Is a type and screen required before transfusing platelets?

Type and Screen for Platelet Transfusion

No, you do not need a type and screen before transfusing platelets in the same way you do for red blood cells. Platelets can be transfused without a formal compatibility crossmatch, though ABO/RhD typing is still recommended for optimal practice.

Key Differences from Red Cell Transfusion

What IS Required:

• ABO/RhD blood type determination of the recipient 1, 2
• Patient identification verification at bedside (critical safety step) 3, 2
• Antibody screen if the patient has been transfused or pregnant within the previous 3 months (sample valid for 72 hours) 2

What is NOT Required:

• Formal serological crossmatch (unlike red blood cells)
• Extended waiting time for compatibility testing
• Platelets can be issued and transfused much more rapidly than red cells

ABO/RhD Considerations for Platelets

ABO Compatibility:

While not mandatory, ABO-compatible platelets are preferred when available 1:

• Platelets express ABO antigens on their surface
• ABO-incompatible platelets may have reduced count increments
• Minor ABO incompatibility (donor plasma antibodies vs. recipient RBCs) can cause hemolysis
• However, ABO-incompatible platelets can be safely transfused when inventory is limited

RhD Considerations:

RhD-negative patients can receive RhD-positive platelets 1:

• Platelets themselves don't express RhD antigens
• Risk of RhD alloimmunization is now very low (1.44% in recent studies) due to reduced RBC contamination in modern platelet products 1
• For women of childbearing potential: Consider RhD-matched platelets or RhIG prophylaxis (20 mg/100 IU per 1 mL RBCs) 1
• For men and post-menopausal women: RhD-positive platelets are acceptable without RhIG 1

Clinical Algorithm

Emergency/Urgent Situations:

1. Verify patient identity at bedside
2. Transfuse ABO-compatible platelets if immediately available
3. If not available, transfuse ABO-incompatible platelets without delay
4. Document transfusion episode

Elective/Prophylactic Transfusions:

1. Obtain ABO/RhD type (can use historical sample if available) 2
2. Check antibody screen if transfused/pregnant within 3 months
3. Select ABO-compatible platelets when possible
4. For RhD-negative women of childbearing age, prefer RhD-negative platelets or give RhIG

Important Caveats

Alloimmunized/Refractory Patients:

• If platelet count should be obtained before transfusion when possible 4, 5
• Consider HLA-matched or crossmatched platelets for documented refractoriness 6
• Refractoriness requires ≥2 poor increments with ABO-compatible, fresh (<72 hours) platelets 6

Monitoring Requirements:

• Vital signs: Pre-transfusion, 15 minutes after start, and at completion 3, 2
• Monitor for transfusion reactions (fever, rash, dyspnea, hypotension)
• Respiratory rate is critical - early sign of serious reactions 2

Common Pitfall to Avoid

Do not delay platelet transfusion waiting for crossmatch results - this is the most critical error. Unlike red cells, platelets do not require serological crossmatching and can be transfused based on ABO/RhD type alone. In bleeding emergencies, even ABO-incompatible platelets should be transfused without delay 7, 8.